Jeff Winton Associates, a full-service communications agency for the pharmaceutical, biotechnology and other life sciences industries, announced expansion into additional global markets through a new partnership with UK-based marketing communications firm Onyx Health.
Bayer secured the rights to an experimental breast cancer drug developed by U.S. biotech firm Systems Oncology LLC in a deal worth up to $370 million.
A review of recent biopharma, biotech and medical device initial public offerings (IPOs).
Anthos Therapeutics is developing next-generation anticoagulants that do not have the bleeding risks that current blood thinners have.
As the world awaits a Covid-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders – antibodies designed specifically to attack this new virus.
Chinese government-linked hackers targeted U.S.-based coronavirus vaccine research developer Moderna Inc. in a bid to steal data, according to a U.S. security official tracking Chinese hacking.
Covid-19 put many businesses on hold, but not biotech. This sector is growing at record speeds, and only a small portion of the capital deals are related to the pandemic.
The Consistent Testing Terminology Working Group published a white paper with industry-wide recommendations for precision medicine testing terms to be utilized in patient education and communication.
Synairgen shares exploded after the announcement of positive results from a clinical trial of the UK-based biotech company’s wholly owned inhaled formulation of interferon beta in Covid-19 patients.
Sanofi is rumored to have a $50 billion budget for mergers and acquisitions and is taking a look at U.S.-based biotech companies, including South San Francisco-based Principia Biopharma.